The Next Step Towards the Elimination of Iodine Deficiency and Preventable Iodine-related Disorders in Europe
EUthyroid2
1 other identifier
interventional
4,500
6 countries
6
Brief Summary
In the EUthyroid2 intervention, measures are being developed and implemented in educational settings across the UK, Germany, Slovenia, the Republic of Cyprus, Bangladesh, and Pakistan to effectively raise awareness of the risks associated with iodine deficiency. Each participating country will employ three measurement points. The intervention will be tailored to the specific contextual characteristics of each implementation site. A process evaluation utilizing a convergent parallel mixed methods design will be conducted, involving surveys of students and teachers, as well as semi-structured interviews.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2024
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 30, 2024
CompletedFirst Submitted
Initial submission to the registry
January 7, 2025
CompletedFirst Posted
Study publicly available on registry
January 30, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedMarch 3, 2025
January 1, 2025
1 year
January 7, 2025
February 27, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in awareness
1\. Change in awareness of iodine and iodine deficiency: Difference in iodine awareness is measured by an iodine awareness questionnaire. The scoring ranges from 1 to 22 points with higher scores indicating a better outcome of awareness.
T1 (baseline) to T2 (2-4 weeks) and T3 (6-8 months) in students (13-17 years)
Secondary Outcomes (4)
Changes between teaching modalities
T1 (baseline) to T2 (2-4 weeks) and T3 (6-8 months)
Changes in vocational schools, high- and secondary schools
T1 (baseline) to T2 (2-4 weeks) and T3 (6-8 months)
Change between age groups and gender distinctions
T1 (baseline) to T2 (2-4 weeks) and T3 (6-8 months)
Change in iodine intake
T1 (baseline) to T2 (2-4 weeks) and T3 (6-8 months)
Study Arms (1)
Teaching programme on iodine
EXPERIMENTALEducational materials: Iodine Feedback Tool, lecture on the topic of iodine and health, booklet, exercises, group assignments and a webpage
Interventions
Educational materials: Iodine Feedback Tool, lecture on the topic of iodine and health, booklet, exercises, group assignments and a webpage This is a pre/post intervention with no control group.
Eligibility Criteria
You may qualify if:
- sufficient language skills to understand the study information, informed consent
You may not qualify if:
- none
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- EUthyroidlead
- EU Horizoncollaborator
- UK Research and Innovationcollaborator
Study Sites (6)
Bangladesh University of Health
Dhaka, 1216, Bangladesh
Cyprus University of Technology
Limassol, 3041, Cyprus
University Medicine Greifswald
Greifswald, 17475, Germany
Islamia College Peshawar
Peshawar, Khyber Pakhtunkhwa, Pakistan
University Medical Centre Ljubljana
Ljubljana, 1000, Slovenia
University of Surrey; Queen's University Belfast
Guildford, GU2 7XH, United Kingdom
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 7, 2025
First Posted
January 30, 2025
Study Start
December 30, 2024
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
March 3, 2025
Record last verified: 2025-01